nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Fluticasone furoate—asthma	0.0602	0.0883	CbGbCtD
Ticagrelor—ABCB1—Indacaterol—asthma	0.0491	0.072	CbGbCtD
Ticagrelor—CYP3A4—Fluticasone furoate—asthma	0.0361	0.0529	CbGbCtD
Ticagrelor—CYP3A4—Budesonide—asthma	0.0322	0.0472	CbGbCtD
Ticagrelor—CYP3A4—Indacaterol—asthma	0.0294	0.0431	CbGbCtD
Ticagrelor—CYP3A4—Ciclesonide—asthma	0.0294	0.0431	CbGbCtD
Ticagrelor—CYP3A4—Salmeterol—asthma	0.0273	0.0401	CbGbCtD
Ticagrelor—CYP3A4—Flunisolide—asthma	0.0273	0.0401	CbGbCtD
Ticagrelor—CYP3A4—Salbutamol—asthma	0.0273	0.0401	CbGbCtD
Ticagrelor—ABCB1—Loratadine—asthma	0.0262	0.0384	CbGbCtD
Ticagrelor—CYP3A4—Zileuton—asthma	0.0244	0.0357	CbGbCtD
Ticagrelor—CYP3A4—Ipratropium bromide—asthma	0.0244	0.0357	CbGbCtD
Ticagrelor—ABCB1—Methylprednisolone—asthma	0.024	0.0352	CbGbCtD
Ticagrelor—CYP3A4—Fluticasone Propionate—asthma	0.0233	0.0341	CbGbCtD
Ticagrelor—CYP3A4—Zafirlukast—asthma	0.0215	0.0315	CbGbCtD
Ticagrelor—CYP3A4—Tiotropium—asthma	0.0185	0.0271	CbGbCtD
Ticagrelor—CYP3A4—Aminophylline—asthma	0.0176	0.0258	CbGbCtD
Ticagrelor—CYP3A4—Theophylline—asthma	0.0166	0.0243	CbGbCtD
Ticagrelor—CYP3A4—Loratadine—asthma	0.0157	0.023	CbGbCtD
Ticagrelor—CYP3A4—Montelukast—asthma	0.0157	0.023	CbGbCtD
Ticagrelor—ABCB1—Betamethasone—asthma	0.0156	0.0229	CbGbCtD
Ticagrelor—ABCB1—Prednisolone—asthma	0.0154	0.0226	CbGbCtD
Ticagrelor—ABCB1—Hydrocortisone—asthma	0.0146	0.0214	CbGbCtD
Ticagrelor—ABCB1—Prednisone—asthma	0.0145	0.0213	CbGbCtD
Ticagrelor—CYP3A4—Methylprednisolone—asthma	0.0144	0.0211	CbGbCtD
Ticagrelor—CYP3A4—Triamcinolone—asthma	0.0109	0.016	CbGbCtD
Ticagrelor—CYP3A4—Betamethasone—asthma	0.00934	0.0137	CbGbCtD
Ticagrelor—CYP3A4—Prednisolone—asthma	0.00922	0.0135	CbGbCtD
Ticagrelor—ABCB1—Dexamethasone—asthma	0.00907	0.0133	CbGbCtD
Ticagrelor—CYP3A4—Hydrocortisone—asthma	0.00874	0.0128	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—asthma	0.0087	0.0128	CbGbCtD
Ticagrelor—CYP3A4—Dexamethasone—asthma	0.00543	0.00797	CbGbCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000126	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AGTR2—asthma	0.000125	0.00161	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD86—asthma	0.000125	0.00161	CbGpPWpGaD
Ticagrelor—Haemorrhage—Triamcinolone—asthma	0.000125	0.000519	CcSEcCtD
Ticagrelor—Haemorrhage—Methylprednisolone—asthma	0.000124	0.000518	CcSEcCtD
Ticagrelor—Eye disorder—Hydrocortisone—asthma	0.000124	0.000515	CcSEcCtD
Ticagrelor—Hypersensitivity—Salbutamol—asthma	0.000124	0.000515	CcSEcCtD
Ticagrelor—CYP3A4—Tryptophan metabolism—CAT—asthma	0.000124	0.00158	CbGpPWpGaD
Ticagrelor—Pruritus—Montelukast—asthma	0.000123	0.000513	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CD40LG—asthma	0.000123	0.00157	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL10—asthma	0.000123	0.00157	CbGpPWpGaD
Ticagrelor—Connective tissue disorder—Methylprednisolone—asthma	0.000122	0.000509	CcSEcCtD
Ticagrelor—Diarrhoea—Arformoterol—asthma	0.000122	0.000507	CcSEcCtD
Ticagrelor—Diarrhoea—Formoterol—asthma	0.000122	0.000507	CcSEcCtD
Ticagrelor—Nausea—Flunisolide—asthma	0.000121	0.000505	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCR3—asthma	0.000121	0.00155	CbGpPWpGaD
Ticagrelor—Asthenia—Salbutamol—asthma	0.00012	0.000502	CcSEcCtD
Ticagrelor—Vomiting—Mometasone—asthma	0.00012	0.000502	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—EDNRB—asthma	0.00012	0.00154	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Budesonide—asthma	0.00012	0.000499	CcSEcCtD
Ticagrelor—Immune system disorder—Hydrocortisone—asthma	0.00012	0.000498	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL4—asthma	0.00012	0.00153	CbGpPWpGaD
Ticagrelor—Rash—Mometasone—asthma	0.000119	0.000498	CcSEcCtD
Ticagrelor—Dermatitis—Mometasone—asthma	0.000119	0.000497	CcSEcCtD
Ticagrelor—Diarrhoea—Montelukast—asthma	0.000119	0.000496	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—NPS—asthma	0.000119	0.00152	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—TAC1—asthma	0.000119	0.00152	CbGpPWpGaD
Ticagrelor—Pruritus—Salbutamol—asthma	0.000119	0.000495	CcSEcCtD
Ticagrelor—Headache—Mometasone—asthma	0.000119	0.000494	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—NPY—asthma	0.000118	0.00151	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PPP2CA—asthma	0.000118	0.00151	CbGpPWpGaD
Ticagrelor—Dizziness—Formoterol—asthma	0.000118	0.00049	CcSEcCtD
Ticagrelor—Dizziness—Arformoterol—asthma	0.000118	0.00049	CcSEcCtD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPA1—asthma	0.000117	0.0015	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—asthma	0.000117	0.0015	CbGpPWpGaD
Ticagrelor—Asthenia—Budesonide—asthma	0.000117	0.000486	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCR3—asthma	0.000117	0.00149	CbGpPWpGaD
Ticagrelor—Eye disorder—Methylprednisolone—asthma	0.000116	0.000484	CcSEcCtD
Ticagrelor—Mental disorder—Hydrocortisone—asthma	0.000116	0.000483	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—PMCH—asthma	0.000116	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRH4—asthma	0.000116	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTGDR2—asthma	0.000116	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NPSR1—asthma	0.000116	0.00148	CbGpPWpGaD
Ticagrelor—Cardiac disorder—Methylprednisolone—asthma	0.000115	0.000481	CcSEcCtD
Ticagrelor—Malnutrition—Hydrocortisone—asthma	0.000115	0.00048	CcSEcCtD
Ticagrelor—Dizziness—Montelukast—asthma	0.000115	0.00048	CcSEcCtD
Ticagrelor—Bradycardia—Dexamethasone—asthma	0.000115	0.00048	CcSEcCtD
Ticagrelor—Bradycardia—Betamethasone—asthma	0.000115	0.00048	CcSEcCtD
Ticagrelor—Pruritus—Budesonide—asthma	0.000115	0.000479	CcSEcCtD
Ticagrelor—Diarrhoea—Salbutamol—asthma	0.000115	0.000479	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—IL2RA—asthma	0.000114	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGTR2—asthma	0.000114	0.00146	CbGpPWpGaD
Ticagrelor—Haemoglobin—Dexamethasone—asthma	0.000114	0.000474	CcSEcCtD
Ticagrelor—Haemoglobin—Betamethasone—asthma	0.000114	0.000474	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CSF2RB—asthma	0.000113	0.00145	CbGpPWpGaD
Ticagrelor—Haemorrhage—Dexamethasone—asthma	0.000113	0.000471	CcSEcCtD
Ticagrelor—Haemorrhage—Betamethasone—asthma	0.000113	0.000471	CcSEcCtD
Ticagrelor—Vomiting—Formoterol—asthma	0.000113	0.000471	CcSEcCtD
Ticagrelor—Vomiting—Arformoterol—asthma	0.000113	0.000471	CcSEcCtD
Ticagrelor—Angiopathy—Methylprednisolone—asthma	0.000113	0.00047	CcSEcCtD
Ticagrelor—Nausea—Mometasone—asthma	0.000113	0.000469	CcSEcCtD
Ticagrelor—Immune system disorder—Methylprednisolone—asthma	0.000112	0.000468	CcSEcCtD
Ticagrelor—Rash—Formoterol—asthma	0.000112	0.000467	CcSEcCtD
Ticagrelor—Rash—Arformoterol—asthma	0.000112	0.000467	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methylprednisolone—asthma	0.000112	0.000467	CcSEcCtD
Ticagrelor—Dermatitis—Arformoterol—asthma	0.000112	0.000467	CcSEcCtD
Ticagrelor—Dermatitis—Formoterol—asthma	0.000112	0.000467	CcSEcCtD
Ticagrelor—Headache—Formoterol—asthma	0.000111	0.000464	CcSEcCtD
Ticagrelor—Headache—Arformoterol—asthma	0.000111	0.000464	CcSEcCtD
Ticagrelor—Diarrhoea—Budesonide—asthma	0.000111	0.000464	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CCR8—asthma	0.000111	0.00142	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TACR2—asthma	0.000111	0.00142	CbGpPWpGaD
Ticagrelor—Dizziness—Salbutamol—asthma	0.000111	0.000463	CcSEcCtD
Ticagrelor—Vomiting—Montelukast—asthma	0.000111	0.000461	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—IL5—asthma	0.000111	0.00142	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—asthma	0.00011	0.00141	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PDGFB—asthma	0.00011	0.00141	CbGpPWpGaD
Ticagrelor—Rash—Montelukast—asthma	0.00011	0.000457	CcSEcCtD
Ticagrelor—Dermatitis—Montelukast—asthma	0.00011	0.000457	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL2RA—asthma	0.00011	0.0014	CbGpPWpGaD
Ticagrelor—Headache—Montelukast—asthma	0.000109	0.000455	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—EDNRB—asthma	0.000109	0.0014	CbGpPWpGaD
Ticagrelor—Mental disorder—Methylprednisolone—asthma	0.000109	0.000454	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CCL17—asthma	0.000109	0.0014	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—NOS2—asthma	0.000109	0.00139	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—C3—asthma	0.000109	0.00139	CbGpPWpGaD
Ticagrelor—Malnutrition—Methylprednisolone—asthma	0.000108	0.000451	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—NPS—asthma	0.000108	0.00138	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—TAC1—asthma	0.000108	0.00138	CbGpPWpGaD
Ticagrelor—Angioedema—Prednisolone—asthma	0.000108	0.000449	CcSEcCtD
Ticagrelor—Dizziness—Budesonide—asthma	0.000108	0.000448	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—PLAU—asthma	0.000107	0.00137	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CDK2—asthma	0.000107	0.00137	CbGpPWpGaD
Ticagrelor—Vomiting—Salbutamol—asthma	0.000107	0.000445	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—BDKRB2—asthma	0.000107	0.00137	CbGpPWpGaD
Ticagrelor—Vertigo—Prednisolone—asthma	0.000106	0.000442	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CXCR3—asthma	0.000106	0.00136	CbGpPWpGaD
Ticagrelor—Rash—Salbutamol—asthma	0.000106	0.000441	CcSEcCtD
Ticagrelor—Syncope—Prednisolone—asthma	0.000106	0.000441	CcSEcCtD
Ticagrelor—Dermatitis—Salbutamol—asthma	0.000106	0.000441	CcSEcCtD
Ticagrelor—Eye disorder—Dexamethasone—asthma	0.000106	0.00044	CcSEcCtD
Ticagrelor—Eye disorder—Betamethasone—asthma	0.000106	0.00044	CcSEcCtD
Ticagrelor—Nausea—Arformoterol—asthma	0.000106	0.00044	CcSEcCtD
Ticagrelor—Nausea—Formoterol—asthma	0.000106	0.00044	CcSEcCtD
Ticagrelor—Angioedema—Hydrocortisone—asthma	0.000105	0.000439	CcSEcCtD
Ticagrelor—Headache—Salbutamol—asthma	0.000105	0.000438	CcSEcCtD
Ticagrelor—Back pain—Triamcinolone—asthma	0.000105	0.000437	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisolone—asthma	0.000104	0.000432	CcSEcCtD
Ticagrelor—Vertigo—Hydrocortisone—asthma	0.000104	0.000431	CcSEcCtD
Ticagrelor—Nausea—Montelukast—asthma	0.000103	0.000431	CcSEcCtD
Ticagrelor—Vomiting—Budesonide—asthma	0.000103	0.000431	CcSEcCtD
Ticagrelor—Syncope—Hydrocortisone—asthma	0.000103	0.000431	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—ADCY2—asthma	0.000103	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL3—asthma	0.000103	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000103	0.00132	CbGpPWpGaD
Ticagrelor—Angiopathy—Dexamethasone—asthma	0.000103	0.000427	CcSEcCtD
Ticagrelor—Angiopathy—Betamethasone—asthma	0.000103	0.000427	CcSEcCtD
Ticagrelor—Rash—Budesonide—asthma	0.000103	0.000427	CcSEcCtD
Ticagrelor—Dermatitis—Budesonide—asthma	0.000102	0.000427	CcSEcCtD
Ticagrelor—Headache—Budesonide—asthma	0.000102	0.000424	CcSEcCtD
Ticagrelor—Hypertension—Prednisolone—asthma	0.000102	0.000424	CcSEcCtD
Ticagrelor—Loss of consciousness—Hydrocortisone—asthma	0.000101	0.000422	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—asthma	0.000101	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—asthma	0.000101	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL5—asthma	0.0001	0.00129	CbGpPWpGaD
Ticagrelor—Bradycardia—Prednisone—asthma	0.0001	0.000418	CcSEcCtD
Ticagrelor—Nausea—Salbutamol—asthma	9.97e-05	0.000415	CcSEcCtD
Ticagrelor—Hypertension—Hydrocortisone—asthma	9.95e-05	0.000414	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—FN1—asthma	9.93e-05	0.00127	CbGpPWpGaD
Ticagrelor—Angioedema—Triamcinolone—asthma	9.92e-05	0.000413	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisone—asthma	9.9e-05	0.000412	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DRB1—asthma	9.9e-05	0.00127	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL2—asthma	9.89e-05	0.00127	CbGpPWpGaD
Ticagrelor—Angioedema—Methylprednisolone—asthma	9.89e-05	0.000412	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—asthma	9.85e-05	0.00041	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—NOS2—asthma	9.81e-05	0.00126	CbGpPWpGaD
Ticagrelor—Vertigo—Triamcinolone—asthma	9.75e-05	0.000406	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	9.74e-05	0.000406	CcSEcCtD
Ticagrelor—Syncope—Triamcinolone—asthma	9.73e-05	0.000405	CcSEcCtD
Ticagrelor—Vertigo—Methylprednisolone—asthma	9.73e-05	0.000405	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—KIF3A—asthma	9.71e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDE4A—asthma	9.71e-05	0.00124	CbGpPWpGaD
Ticagrelor—Syncope—Methylprednisolone—asthma	9.71e-05	0.000404	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—KNG1—asthma	9.71e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—BDKRB2—asthma	9.69e-05	0.00124	CbGpPWpGaD
Ticagrelor—Connective tissue disorder—Prednisone—asthma	9.68e-05	0.000403	CcSEcCtD
Ticagrelor—Nausea—Budesonide—asthma	9.66e-05	0.000402	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—AGTR1—asthma	9.65e-05	0.00124	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Triamcinolone—asthma	9.54e-05	0.000397	CcSEcCtD
Ticagrelor—Loss of consciousness—Methylprednisolone—asthma	9.52e-05	0.000396	CcSEcCtD
Ticagrelor—Shock—Prednisolone—asthma	9.47e-05	0.000395	CcSEcCtD
Ticagrelor—Cough—Triamcinolone—asthma	9.47e-05	0.000394	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL10—asthma	9.43e-05	0.00121	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADCY2—asthma	9.37e-05	0.0012	CbGpPWpGaD
Ticagrelor—Hypertension—Triamcinolone—asthma	9.37e-05	0.00039	CcSEcCtD
Ticagrelor—Hypertension—Methylprednisolone—asthma	9.35e-05	0.000389	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—IL3—asthma	9.34e-05	0.0012	CbGpPWpGaD
Ticagrelor—Shock—Hydrocortisone—asthma	9.25e-05	0.000385	CcSEcCtD
Ticagrelor—Nervous system disorder—Hydrocortisone—asthma	9.22e-05	0.000384	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—asthma	9.21e-05	0.000383	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	9.16e-05	0.00117	CbGpPWpGaD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	9.15e-05	0.000381	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB2—asthma	9.15e-05	0.00117	CbGpPWpGaD
Ticagrelor—Skin disorder—Hydrocortisone—asthma	9.14e-05	0.000381	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CYSLTR1—asthma	9.09e-05	0.00116	CbGpPWpGaD
Ticagrelor—Angioedema—Dexamethasone—asthma	9e-05	0.000375	CcSEcCtD
Ticagrelor—Angioedema—Betamethasone—asthma	9e-05	0.000375	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—asthma	8.94e-05	0.000372	CcSEcCtD
Ticagrelor—Confusional state—Methylprednisolone—asthma	8.91e-05	0.000371	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—asthma	8.9e-05	0.000371	CcSEcCtD
Ticagrelor—Vertigo—Betamethasone—asthma	8.85e-05	0.000368	CcSEcCtD
Ticagrelor—Vertigo—Dexamethasone—asthma	8.85e-05	0.000368	CcSEcCtD
Ticagrelor—Syncope—Dexamethasone—asthma	8.83e-05	0.000368	CcSEcCtD
Ticagrelor—Syncope—Betamethasone—asthma	8.83e-05	0.000368	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—KNG1—asthma	8.81e-05	0.00113	CbGpPWpGaD
Ticagrelor—Hypotension—Hydrocortisone—asthma	8.79e-05	0.000366	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—C5AR1—asthma	8.78e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL11—asthma	8.78e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CMA1—asthma	8.78e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—UTS2—asthma	8.78e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VIP—asthma	8.78e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGTR1—asthma	8.76e-05	0.00112	CbGpPWpGaD
Ticagrelor—Shock—Triamcinolone—asthma	8.71e-05	0.000363	CcSEcCtD
Ticagrelor—Shock—Methylprednisolone—asthma	8.69e-05	0.000362	CcSEcCtD
Ticagrelor—Nervous system disorder—Methylprednisolone—asthma	8.67e-05	0.000361	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—ITPR1—asthma	8.66e-05	0.00111	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Betamethasone—asthma	8.65e-05	0.00036	CcSEcCtD
Ticagrelor—Loss of consciousness—Dexamethasone—asthma	8.65e-05	0.00036	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisolone—asthma	8.65e-05	0.00036	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—asthma	8.63e-05	0.000359	CcSEcCtD
Ticagrelor—Skin disorder—Methylprednisolone—asthma	8.58e-05	0.000358	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—asthma	8.57e-05	0.000357	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL10—asthma	8.56e-05	0.0011	CbGpPWpGaD
Ticagrelor—Hypertension—Betamethasone—asthma	8.5e-05	0.000354	CcSEcCtD
Ticagrelor—Hypertension—Dexamethasone—asthma	8.5e-05	0.000354	CcSEcCtD
Ticagrelor—Paraesthesia—Hydrocortisone—asthma	8.45e-05	0.000352	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CCR4—asthma	8.42e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB2—asthma	8.31e-05	0.00106	CbGpPWpGaD
Ticagrelor—Dyspepsia—Hydrocortisone—asthma	8.28e-05	0.000345	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—asthma	8.26e-05	0.00106	CbGpPWpGaD
Ticagrelor—Hypotension—Methylprednisolone—asthma	8.26e-05	0.000344	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—STAT6—asthma	8.26e-05	0.00106	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—asthma	8.24e-05	0.00106	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDN1—asthma	8.18e-05	0.00105	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Hydrocortisone—asthma	8.12e-05	0.000338	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—asthma	8.12e-05	0.00104	CbGpPWpGaD
Ticagrelor—Fatigue—Hydrocortisone—asthma	8.11e-05	0.000338	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—IL2RB—asthma	8.1e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDE4D—asthma	8.03e-05	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CSF2—asthma	7.99e-05	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—RHOA—asthma	7.97e-05	0.00102	CbGpPWpGaD
Ticagrelor—Paraesthesia—Triamcinolone—asthma	7.95e-05	0.000331	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisolone—asthma	7.94e-05	0.000331	CcSEcCtD
Ticagrelor—Paraesthesia—Methylprednisolone—asthma	7.93e-05	0.000331	CcSEcCtD
Ticagrelor—Shock—Dexamethasone—asthma	7.91e-05	0.000329	CcSEcCtD
Ticagrelor—Shock—Betamethasone—asthma	7.91e-05	0.000329	CcSEcCtD
Ticagrelor—Dyspnoea—Triamcinolone—asthma	7.9e-05	0.000329	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—NOS3—asthma	7.89e-05	0.00101	CbGpPWpGaD
Ticagrelor—Nervous system disorder—Dexamethasone—asthma	7.88e-05	0.000328	CcSEcCtD
Ticagrelor—Nervous system disorder—Betamethasone—asthma	7.88e-05	0.000328	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—ITPR1—asthma	7.86e-05	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	7.86e-05	0.00101	CbGpPWpGaD
Ticagrelor—Angioedema—Prednisone—asthma	7.83e-05	0.000326	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—C5—asthma	7.83e-05	0.001	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDE4B—asthma	7.83e-05	0.001	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TACR1—asthma	7.83e-05	0.001	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—asthma	7.82e-05	0.001	CbGpPWpGaD
Ticagrelor—Dyspepsia—Triamcinolone—asthma	7.8e-05	0.000325	CcSEcCtD
Ticagrelor—Dyspepsia—Methylprednisolone—asthma	7.78e-05	0.000324	CcSEcCtD
Ticagrelor—Feeling abnormal—Hydrocortisone—asthma	7.75e-05	0.000323	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	7.72e-05	0.000989	CbGpPWpGaD
Ticagrelor—Vertigo—Prednisone—asthma	7.7e-05	0.000321	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Hydrocortisone—asthma	7.69e-05	0.00032	CcSEcCtD
Ticagrelor—Syncope—Prednisone—asthma	7.69e-05	0.00032	CcSEcCtD
Ticagrelor—Fatigue—Triamcinolone—asthma	7.64e-05	0.000318	CcSEcCtD
Ticagrelor—Fatigue—Methylprednisolone—asthma	7.62e-05	0.000317	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—asthma	7.54e-05	0.000314	CcSEcCtD
Ticagrelor—Hypotension—Dexamethasone—asthma	7.51e-05	0.000313	CcSEcCtD
Ticagrelor—Hypotension—Betamethasone—asthma	7.51e-05	0.000313	CcSEcCtD
Ticagrelor—Abdominal pain—Hydrocortisone—asthma	7.44e-05	0.00031	CcSEcCtD
Ticagrelor—Body temperature increased—Hydrocortisone—asthma	7.44e-05	0.00031	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—EDN1—asthma	7.43e-05	0.000952	CbGpPWpGaD
Ticagrelor—Hypertension—Prednisone—asthma	7.4e-05	0.000308	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—asthma	7.37e-05	0.000944	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PLA2G4A—asthma	7.34e-05	0.000941	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR5—asthma	7.31e-05	0.000937	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Triamcinolone—asthma	7.3e-05	0.000304	CcSEcCtD
Ticagrelor—Feeling abnormal—Methylprednisolone—asthma	7.28e-05	0.000303	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CSF2—asthma	7.26e-05	0.00093	CbGpPWpGaD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	7.25e-05	0.000302	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—asthma	7.23e-05	0.000926	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Methylprednisolone—asthma	7.23e-05	0.000301	CcSEcCtD
Ticagrelor—Paraesthesia—Betamethasone—asthma	7.22e-05	0.000301	CcSEcCtD
Ticagrelor—Paraesthesia—Dexamethasone—asthma	7.22e-05	0.000301	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2RA—asthma	7.21e-05	0.000923	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR3—asthma	7.16e-05	0.000917	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—C3—asthma	7.15e-05	0.000915	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisolone—asthma	7.1e-05	0.000296	CcSEcCtD
Ticagrelor—Dyspepsia—Betamethasone—asthma	7.07e-05	0.000295	CcSEcCtD
Ticagrelor—Dyspepsia—Dexamethasone—asthma	7.07e-05	0.000295	CcSEcCtD
Ticagrelor—Body temperature increased—Triamcinolone—asthma	7e-05	0.000292	CcSEcCtD
Ticagrelor—Abdominal pain—Methylprednisolone—asthma	6.99e-05	0.000291	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—NPY—asthma	6.98e-05	0.000894	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	6.94e-05	0.000889	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Dexamethasone—asthma	6.94e-05	0.000289	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Betamethasone—asthma	6.94e-05	0.000289	CcSEcCtD
Ticagrelor—Hypersensitivity—Hydrocortisone—asthma	6.93e-05	0.000289	CcSEcCtD
Ticagrelor—Fatigue—Dexamethasone—asthma	6.93e-05	0.000289	CcSEcCtD
Ticagrelor—Fatigue—Betamethasone—asthma	6.93e-05	0.000289	CcSEcCtD
Ticagrelor—Shock—Prednisone—asthma	6.88e-05	0.000287	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—asthma	6.86e-05	0.000286	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—asthma	6.8e-05	0.000283	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—PPP2CA—asthma	6.76e-05	0.000866	CbGpPWpGaD
Ticagrelor—Asthenia—Hydrocortisone—asthma	6.75e-05	0.000281	CcSEcCtD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	6.75e-05	0.000864	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGTR2—asthma	6.73e-05	0.000862	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—asthma	6.72e-05	0.000861	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—ALDH2—asthma	6.71e-05	0.000859	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2—asthma	6.68e-05	0.000856	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	6.67e-05	0.000855	CbGpPWpGaD
Ticagrelor—Pruritus—Hydrocortisone—asthma	6.65e-05	0.000277	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCR5—asthma	6.64e-05	0.000851	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Betamethasone—asthma	6.62e-05	0.000276	CcSEcCtD
Ticagrelor—Feeling abnormal—Dexamethasone—asthma	6.62e-05	0.000276	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dexamethasone—asthma	6.57e-05	0.000274	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Betamethasone—asthma	6.57e-05	0.000274	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—IL2RA—asthma	6.54e-05	0.000838	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Triamcinolone—asthma	6.52e-05	0.000272	CcSEcCtD
Ticagrelor—Hypersensitivity—Methylprednisolone—asthma	6.51e-05	0.000271	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—C3—asthma	6.49e-05	0.000831	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—asthma	6.45e-05	0.000826	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDNRB—asthma	6.45e-05	0.000826	CbGpPWpGaD
Ticagrelor—Diarrhoea—Hydrocortisone—asthma	6.44e-05	0.000268	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL2—asthma	6.42e-05	0.000823	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NPS—asthma	6.38e-05	0.000817	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TAC1—asthma	6.38e-05	0.000817	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTT1—asthma	6.38e-05	0.000817	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisolone—asthma	6.37e-05	0.000265	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	6.35e-05	0.000814	CbGpPWpGaD
Ticagrelor—Asthenia—Triamcinolone—asthma	6.35e-05	0.000265	CcSEcCtD
Ticagrelor—Abdominal pain—Betamethasone—asthma	6.35e-05	0.000265	CcSEcCtD
Ticagrelor—Body temperature increased—Dexamethasone—asthma	6.35e-05	0.000265	CcSEcCtD
Ticagrelor—Body temperature increased—Betamethasone—asthma	6.35e-05	0.000265	CcSEcCtD
Ticagrelor—Abdominal pain—Dexamethasone—asthma	6.35e-05	0.000265	CcSEcCtD
Ticagrelor—Asthenia—Methylprednisolone—asthma	6.34e-05	0.000264	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	6.3e-05	0.000808	CbGpPWpGaD
Ticagrelor—Paraesthesia—Prednisone—asthma	6.28e-05	0.000262	CcSEcCtD
Ticagrelor—Pruritus—Triamcinolone—asthma	6.27e-05	0.000261	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CXCR3—asthma	6.26e-05	0.000802	CbGpPWpGaD
Ticagrelor—Pruritus—Methylprednisolone—asthma	6.25e-05	0.00026	CcSEcCtD
Ticagrelor—Dizziness—Hydrocortisone—asthma	6.22e-05	0.000259	CcSEcCtD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	6.17e-05	0.00079	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	6.17e-05	0.00079	CbGpPWpGaD
Ticagrelor—Dyspepsia—Prednisone—asthma	6.16e-05	0.000257	CcSEcCtD
Ticagrelor—Rash—Prednisolone—asthma	6.07e-05	0.000253	CcSEcCtD
Ticagrelor—Dermatitis—Prednisolone—asthma	6.07e-05	0.000253	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	6.07e-05	0.000777	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CYBA—asthma	6.06e-05	0.000776	CbGpPWpGaD
Ticagrelor—Diarrhoea—Methylprednisolone—asthma	6.05e-05	0.000252	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—asthma	6.03e-05	0.000251	CcSEcCtD
Ticagrelor—Headache—Prednisolone—asthma	6.03e-05	0.000251	CcSEcCtD
Ticagrelor—Constipation—Prednisone—asthma	5.98e-05	0.000249	CcSEcCtD
Ticagrelor—Vomiting—Hydrocortisone—asthma	5.98e-05	0.000249	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—IL5—asthma	5.93e-05	0.00076	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PARP1—asthma	5.93e-05	0.00076	CbGpPWpGaD
Ticagrelor—Rash—Hydrocortisone—asthma	5.93e-05	0.000247	CcSEcCtD
Ticagrelor—Dermatitis—Hydrocortisone—asthma	5.92e-05	0.000247	CcSEcCtD
Ticagrelor—Headache—Hydrocortisone—asthma	5.89e-05	0.000245	CcSEcCtD
Ticagrelor—Dizziness—Triamcinolone—asthma	5.86e-05	0.000244	CcSEcCtD
Ticagrelor—Dizziness—Methylprednisolone—asthma	5.84e-05	0.000243	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisone—asthma	5.77e-05	0.00024	CcSEcCtD
Ticagrelor—Asthenia—Betamethasone—asthma	5.77e-05	0.00024	CcSEcCtD
Ticagrelor—Asthenia—Dexamethasone—asthma	5.77e-05	0.00024	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—BDKRB2—asthma	5.72e-05	0.000733	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Prednisone—asthma	5.72e-05	0.000238	CcSEcCtD
Ticagrelor—Nausea—Prednisolone—asthma	5.72e-05	0.000238	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—asthma	5.71e-05	0.000732	CbGpPWpGaD
Ticagrelor—Pruritus—Betamethasone—asthma	5.69e-05	0.000237	CcSEcCtD
Ticagrelor—Pruritus—Dexamethasone—asthma	5.69e-05	0.000237	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—VEGFA—asthma	5.68e-05	0.000728	CbGpPWpGaD
Ticagrelor—Vomiting—Triamcinolone—asthma	5.63e-05	0.000235	CcSEcCtD
Ticagrelor—Vomiting—Methylprednisolone—asthma	5.62e-05	0.000234	CcSEcCtD
Ticagrelor—Nausea—Hydrocortisone—asthma	5.59e-05	0.000233	CcSEcCtD
Ticagrelor—Rash—Triamcinolone—asthma	5.58e-05	0.000233	CcSEcCtD
Ticagrelor—Dermatitis—Triamcinolone—asthma	5.58e-05	0.000232	CcSEcCtD
Ticagrelor—Rash—Methylprednisolone—asthma	5.57e-05	0.000232	CcSEcCtD
Ticagrelor—Dermatitis—Methylprednisolone—asthma	5.57e-05	0.000232	CcSEcCtD
Ticagrelor—Headache—Triamcinolone—asthma	5.55e-05	0.000231	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—ADCY2—asthma	5.54e-05	0.000709	CbGpPWpGaD
Ticagrelor—Headache—Methylprednisolone—asthma	5.54e-05	0.000231	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—asthma	5.53e-05	0.00023	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—asthma	5.53e-05	0.00023	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—IL3—asthma	5.52e-05	0.000707	CbGpPWpGaD
Ticagrelor—Diarrhoea—Dexamethasone—asthma	5.5e-05	0.000229	CcSEcCtD
Ticagrelor—Diarrhoea—Betamethasone—asthma	5.5e-05	0.000229	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—asthma	5.46e-05	0.000699	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	5.41e-05	0.000693	CbGpPWpGaD
Ticagrelor—Dizziness—Dexamethasone—asthma	5.31e-05	0.000221	CcSEcCtD
Ticagrelor—Dizziness—Betamethasone—asthma	5.31e-05	0.000221	CcSEcCtD
Ticagrelor—Nausea—Triamcinolone—asthma	5.26e-05	0.000219	CcSEcCtD
Ticagrelor—Nausea—Methylprednisolone—asthma	5.25e-05	0.000219	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—TGFB1—asthma	5.21e-05	0.000668	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KNG1—asthma	5.21e-05	0.000667	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—asthma	5.19e-05	0.000665	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGTR1—asthma	5.18e-05	0.000663	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisone—asthma	5.16e-05	0.000215	CcSEcCtD
Ticagrelor—Vomiting—Dexamethasone—asthma	5.11e-05	0.000213	CcSEcCtD
Ticagrelor—Vomiting—Betamethasone—asthma	5.11e-05	0.000213	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—asthma	5.08e-05	0.00065	CbGpPWpGaD
Ticagrelor—Rash—Dexamethasone—asthma	5.07e-05	0.000211	CcSEcCtD
Ticagrelor—Rash—Betamethasone—asthma	5.07e-05	0.000211	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	5.06e-05	0.000649	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6R—asthma	5.06e-05	0.000649	CbGpPWpGaD
Ticagrelor—Dermatitis—Dexamethasone—asthma	5.06e-05	0.000211	CcSEcCtD
Ticagrelor—Dermatitis—Betamethasone—asthma	5.06e-05	0.000211	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CXCL10—asthma	5.06e-05	0.000648	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—RHOA—asthma	5.04e-05	0.000645	CbGpPWpGaD
Ticagrelor—Headache—Betamethasone—asthma	5.03e-05	0.00021	CcSEcCtD
Ticagrelor—Headache—Dexamethasone—asthma	5.03e-05	0.00021	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—asthma	5.02e-05	0.000209	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—asthma	5.01e-05	0.000642	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NTRK1—asthma	4.96e-05	0.000636	CbGpPWpGaD
Ticagrelor—Pruritus—Prednisone—asthma	4.95e-05	0.000206	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—ADRB2—asthma	4.91e-05	0.000629	CbGpPWpGaD
Ticagrelor—Diarrhoea—Prednisone—asthma	4.79e-05	0.000199	CcSEcCtD
Ticagrelor—Nausea—Betamethasone—asthma	4.77e-05	0.000199	CcSEcCtD
Ticagrelor—Nausea—Dexamethasone—asthma	4.77e-05	0.000199	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—TNF—asthma	4.68e-05	0.000599	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ITPR1—asthma	4.64e-05	0.000595	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisone—asthma	4.63e-05	0.000193	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—RHOA—asthma	4.57e-05	0.000586	CbGpPWpGaD
Ticagrelor—Vomiting—Prednisone—asthma	4.45e-05	0.000185	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CD86—asthma	4.42e-05	0.000567	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—asthma	4.42e-05	0.000567	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—asthma	4.42e-05	0.000566	CbGpPWpGaD
Ticagrelor—Rash—Prednisone—asthma	4.41e-05	0.000184	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—asthma	4.41e-05	0.000184	CcSEcCtD
Ticagrelor—ABCB1—Metabolism—LTC4S—asthma	4.4e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—asthma	4.39e-05	0.000562	CbGpPWpGaD
Ticagrelor—Headache—Prednisone—asthma	4.38e-05	0.000183	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—asthma	4.36e-05	0.000559	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—asthma	4.35e-05	0.000558	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLA2G4A—asthma	4.34e-05	0.000556	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CSF2—asthma	4.29e-05	0.000549	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—asthma	4.22e-05	0.000541	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SMAD3—asthma	4.17e-05	0.000535	CbGpPWpGaD
Ticagrelor—Nausea—Prednisone—asthma	4.16e-05	0.000173	CcSEcCtD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	4.15e-05	0.000531	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—asthma	4.06e-05	0.000521	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—asthma	4.01e-05	0.000514	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—asthma	4.01e-05	0.000514	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PPP2CA—asthma	3.99e-05	0.000512	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR5—asthma	3.92e-05	0.000503	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2RA—asthma	3.87e-05	0.000495	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—asthma	3.84e-05	0.000491	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—C3—asthma	3.83e-05	0.000491	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LTA4H—asthma	3.81e-05	0.000488	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDGFB—asthma	3.73e-05	0.000478	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.6e-05	0.000461	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—asthma	3.57e-05	0.000457	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	3.42e-05	0.000438	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FN1—asthma	3.37e-05	0.000431	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ARG1—asthma	3.33e-05	0.000427	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	3.08e-05	0.000394	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—asthma	3.07e-05	0.000393	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH7A1—asthma	3.01e-05	0.000386	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—asthma	3e-05	0.000384	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6R—asthma	2.99e-05	0.000383	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.98e-05	0.000382	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—asthma	2.93e-05	0.000376	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ARG2—asthma	2.89e-05	0.00037	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—asthma	2.87e-05	0.000368	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—asthma	2.8e-05	0.000359	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LTC4S—asthma	2.71e-05	0.000347	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RHOA—asthma	2.7e-05	0.000346	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.69e-05	0.000345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—asthma	2.67e-05	0.000342	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	2.58e-05	0.000331	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.47e-05	0.000317	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.42e-05	0.000311	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX15—asthma	2.39e-05	0.000307	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5AP—asthma	2.39e-05	0.000307	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—asthma	2.37e-05	0.000304	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LTA4H—asthma	2.35e-05	0.000301	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.31e-05	0.000296	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CHAT—asthma	2.28e-05	0.000293	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—asthma	2.27e-05	0.00029	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—asthma	2.25e-05	0.000289	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—asthma	2.14e-05	0.000275	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—asthma	2.13e-05	0.000273	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ARG1—asthma	2.05e-05	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5—asthma	2.04e-05	0.000261	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CARM1—asthma	1.94e-05	0.000249	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—asthma	1.93e-05	0.000247	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DCN—asthma	1.91e-05	0.000245	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—asthma	1.91e-05	0.000244	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH2—asthma	1.86e-05	0.000239	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH7A1—asthma	1.86e-05	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ARG2—asthma	1.78e-05	0.000228	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—asthma	1.77e-05	0.000227	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—asthma	1.77e-05	0.000226	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—asthma	1.73e-05	0.000222	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—asthma	1.55e-05	0.000199	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5AP—asthma	1.48e-05	0.000189	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX15—asthma	1.48e-05	0.000189	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NQO1—asthma	1.47e-05	0.000189	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADCY2—asthma	1.44e-05	0.000185	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CHAT—asthma	1.41e-05	0.00018	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—asthma	1.33e-05	0.000171	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5—asthma	1.25e-05	0.000161	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—asthma	1.23e-05	0.000157	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—asthma	1.21e-05	0.000155	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ITPR1—asthma	1.21e-05	0.000155	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CARM1—asthma	1.2e-05	0.000153	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—asthma	1.19e-05	0.000153	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DCN—asthma	1.18e-05	0.000151	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH2—asthma	1.15e-05	0.000147	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G4A—asthma	1.13e-05	0.000145	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—asthma	1.13e-05	0.000145	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—asthma	1.09e-05	0.00014	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP2CA—asthma	1.04e-05	0.000133	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NQO1—asthma	9.07e-06	0.000116	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADCY2—asthma	8.87e-06	0.000114	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—asthma	7.97e-06	0.000102	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—asthma	7.56e-06	9.69e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—asthma	7.46e-06	9.56e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ITPR1—asthma	7.44e-06	9.53e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—asthma	7.36e-06	9.43e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—asthma	7.27e-06	9.31e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—asthma	6.95e-06	8.91e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G4A—asthma	6.95e-06	8.9e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—asthma	6.95e-06	8.9e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP2CA—asthma	6.4e-06	8.2e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—asthma	6.36e-06	8.15e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—asthma	5.55e-06	7.11e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—asthma	4.91e-06	6.29e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—asthma	4.48e-06	5.74e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—asthma	4.28e-06	5.49e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—asthma	3.92e-06	5.02e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—asthma	3.42e-06	4.38e-05	CbGpPWpGaD
